JPMorgan Chase & Co. Has $3.64 Million Holdings in The Pennant Group, Inc. (NASDAQ:PNTG)

JPMorgan Chase & Co. lowered its position in shares of The Pennant Group, Inc. (NASDAQ:PNTG - Free Report) by 33.4% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 137,151 shares of the company's stock after selling 68,771 shares during the quarter. JPMorgan Chase & Co. owned approximately 0.40% of The Pennant Group worth $3,637,000 at the end of the most recent quarter.

Several other institutional investors have also recently added to or reduced their stakes in PNTG. Van Berkom & Associates Inc. increased its holdings in shares of The Pennant Group by 2,635.6% during the fourth quarter. Van Berkom & Associates Inc. now owns 2,198,216 shares of the company's stock worth $58,297,000 after buying an additional 2,117,859 shares in the last quarter. Vanguard Group Inc. increased its holdings in The Pennant Group by 11.0% during the 4th quarter. Vanguard Group Inc. now owns 2,261,564 shares of the company's stock valued at $59,977,000 after purchasing an additional 223,919 shares in the last quarter. Raymond James Financial Inc. bought a new position in The Pennant Group in the 4th quarter valued at $2,570,000. Hussman Strategic Advisors Inc. acquired a new position in The Pennant Group in the fourth quarter worth $1,114,000. Finally, Charles Schwab Investment Management Inc. grew its holdings in shares of The Pennant Group by 17.2% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 284,391 shares of the company's stock worth $7,542,000 after purchasing an additional 41,648 shares during the last quarter. 85.88% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several brokerages recently issued reports on PNTG. Truist Financial reduced their price target on shares of The Pennant Group from $32.00 to $28.00 and set a "hold" rating on the stock in a research report on Friday, March 7th. Stephens reissued an "overweight" rating and set a $38.00 price target on shares of The Pennant Group in a research note on Wednesday, April 2nd. Two equities research analysts have rated the stock with a hold rating and three have given a buy rating to the stock. According to data from MarketBeat, The Pennant Group has a consensus rating of "Moderate Buy" and a consensus target price of $34.80.

The Pennant Group Trading Down 1.1 %

NASDAQ:PNTG traded down $0.28 on Friday, hitting $25.29. 22,749 shares of the stock were exchanged, compared to its average volume of 224,990. The Pennant Group, Inc. has a 52 week low of $20.11 and a 52 week high of $37.13. The company's 50-day moving average price is $24.67 and its 200 day moving average price is $27.99. The company has a debt-to-equity ratio of 0.58, a quick ratio of 1.12 and a current ratio of 1.12. The stock has a market capitalization of $877.95 million, a price-to-earnings ratio of 37.10, a P/E/G ratio of 2.24 and a beta of 1.73.

About The Pennant Group

The Pennant Group, Inc provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families.